Upadacitinib vs Adalimumab in PsA using RAPID3
Management Strategies for Psoriatic Arthritis
Challenges and Opportunities in Achieving Treat-to-Target in Psoriatic Arthritis
Psoriatic Arthritis Panel Discussion: ACR21
PROs in Psoriatic Arthritis: Dr. Antoni Chan
Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures -- ep. 14 of 32
Tuesday Night Rheumatology - Psoriatic Arthritis Highlights from RNL 2021
TNR: Psoriatic Arthritis Journal Club
Bimekizumab treatment in patients with psoriatic arthritis and TNFi-IR: results up to 1 year
Dr Martin Bergman at RWCS 2018 on Disease Activity Measures
Psoriatic Arthritis Panel Discussion
Disease Measures in Rheumatoid Arthritis -- ep. 17 of 32
Clinical Debates in Psoriatic Arthritis: Is a JAK Inhibitor Right for This Patient?
CAPES: Spondyloarthritis and Psoriatic Arthritis Treatment Update Clinician CME Webinar
Psoriatic Disease in Women of Childbearing Age
Psoriatic Arthritis: More than meets the eyes by Dr Frances Leung.
Research Update: The Latest News About Psoriasis and Psoriatic Arthritis
Psoriatic Arthritis: New Choices and Treatment Options
Expert Recommendations from ACR on Psoriatic Arthritis, Ankylosing Spondylitis, Lupus, Vasculitis.
Mapping the Path to Better Patient Outcomes in Rheumatoid Arthritis and Psoriatic Arthritis
